Farallon Capital Management LLC Enanta Pharmaceuticals Inc Transaction History

Farallon Capital Management LLC

$19.9 Billion
Q3 2024

A detailed history of Farallon Capital Management LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,108,262 shares of ENTA stock, worth $19.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,108,262

Previous 2,095,000 0.63%

Holding current value

$19.1 Million

Previous $27.2 Million 19.54%

% of portfolio

0.11%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.05 - $16.54 $133,283 - $219,353	13,262 Added 0.63%	2,108,262 $21.9 Million
Q1 2024 May 15, 2024	BUY	$10.08 - $17.46 $705,600 - $1.22 Million	70,000 Added 3.46%	2,095,000 $36.6 Million
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $16.6 Million - $21.8 Million	2,025,000 New	2,025,000 $19.1 Million
Q3 2023 Nov 14, 2023	BUY	$11.09 - $22.13 $20.8 Million - $41.5 Million	1,875,000 New	1,875,000 $20.9 Million
Q2 2023 Aug 14, 2023	BUY	$20.68 - $39.85 $6.72 Million - $13 Million	325,000 Added 20.97%	1,875,000 $40.1 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $1.34 Million - $1.77 Million	-23,829 Reduced 1.51%	1,550,000 $110 Million
Q4 2021 Feb 14, 2022	SELL	$60.19 - $97.37 $25.4 Million - $41 Million	-421,171 Reduced 21.11%	1,573,829 $118 Million
Q1 2021 May 17, 2021	BUY	$41.69 - $54.95 $9.17 Million - $12.1 Million	220,000 Added 12.39%	1,995,000 $98.4 Million
Q3 2020 Nov 16, 2020	BUY	$43.36 - $53.53 $1.08 Million - $1.34 Million	25,000 Added 1.43%	1,775,000 $81.3 Million
Q4 2019 Feb 13, 2020	BUY	$57.95 - $66.61 $27.6 Million - $31.7 Million	475,788 Added 37.34%	1,750,000 $108 Million
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $18.9 Million - $27.7 Million	314,212 Added 32.73%	1,274,212 $76.6 Million
Q2 2019 Aug 14, 2019	BUY	$81.3 - $97.35 $1.63 Million - $1.95 Million	20,000 Added 2.13%	960,000 $81 Million
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $1.04 Million - $1.58 Million	15,000 Added 1.62%	940,000 $89.8 Million
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $3.76 Million - $4.87 Million	57,500 Added 6.63%	925,000 $65.5 Million
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $17.7 Million - $26.2 Million	-207,500 Reduced 19.3%	867,500 $74.1 Million
Q2 2018 Aug 14, 2018	BUY	$81.85 - $120.51 $13.1 Million - $19.3 Million	160,000 Added 17.49%	1,075,000 $125 Million
Q1 2018 May 15, 2018	SELL	$57.91 - $92.15 $579,100 - $921,500	-10,000 Reduced 1.08%	915,000 $74 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $23.4 Million - $30.4 Million	512,667 Added 124.33%	925,000 $54.3 Million
Q3 2017 Nov 14, 2017	BUY	$37.91 - $46.8 $15.6 Million - $19.3 Million	412,333	412,333 $19.3 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $188M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Account

Farallon Capital Management LLC Enanta Pharmaceuticals Inc Transaction History